Immune-mediated mechanisms of atherosclerosis and implications for the clinic. (2016)
Attributed to:
Low dose interleukin (IL)-2 in patients with a recent acute coronary syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.4651
Publication URI: https://www.repository.cam.ac.uk/handle/1810/260417
Type: Journal Article/Review